CLOSEOUT LETTER
Encore Vapor Inc
- Recipient:
- Encore Vapor Inc
United States
- Issuing Office:
United States
Center for Tobacco Products 10903 New Hampshire Avenue Silver Spring, MD 20993 |
VIA Electronic Mail
FEB 8, 2017
Encore Vapor Inc.
Attn: Josh Jenkins
http://www.buyencore.com
sales@encorevapor.com
Dear Mr. Jenkins:
The United States Food and Drug Administration 's (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions following the issuance of our Warning Letter dated September 29, 2016, and teleconference held on September 30, 2016. Based on our evaluation, it appears that you have taken steps to address the violation contained in the Warning Letter for the website http://www.buyencore.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
Bryan Hills
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
Domains by Proxy, LLC
BUYENCORE.com@domainsbyproxy.com
Godaddy.com, LLC
abuse@godaddy.com
3dCart Shopping Cart Software
Attn: Gonzalo J. Gill
gil@3dcart.com